Eleanor Madders

Eleanor joined Gentronix in November 2020 as a trainee Study Director. After 11 months of training and the completion of her PhD in cancer biology and DNA repair, she is now a GLP gene mutation Study Director. Eleanor is also responsible for overseeing all aspects of the mouse lymphoma assay, OECD 490, here at Gentronix.